4 Einträge gefunden

1. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
3. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment

   1. Bauer, Emanuel C A
   2. Schochter, Fabienne
   3. Widschwendter, Peter
   4. DeGregorio, Amelie
   5. Andergassen, Ulrich
   6. Friedl, Thomas W P
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
4. Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

   1. Barrdahl, Myrto
   2. Rudolph, Anja
   3. Hopper, John L
   4. Southey, Melissa C
   5. Broeks, Annegien
   6. Fasching, Peter A
   7. Beckmann, Matthias W

   2017 - Forschungsinformationssystem des UKE